BLES Biochemicals Inc. maintains a pharmacovigilance system to monitor and evaluate safety information for our medicinal products.
We continuously assess benefit-risk information and take action where appropriate to support patient safety and regulatory compliance.
What is pharmacovigilance?
Pharmacovigilance is the science and activities related to the detection, assessment, understanding and prevention of adverse effects
or any other medicine-related problem.
The objective is to prevent harm from adverse reactions and promote the safe and effective use of medicinal products by providing timely
information to healthcare professionals, patients and health authorities.
What is an adverse drug reaction?
An adverse drug reaction is a harmful and unintended response to a medicinal product where a causal relationship is at least a reasonable possibility.
Reactions may arise from authorized use or from use outside approved terms, including off-label use, overdose, misuse, abuse and medication errors.
What to report
Suspected adverse drug reactions
Medication errors, including near-misses
Product quality complaints with potential clinical impact
Special situations (pregnancy exposure, lactation exposure, overdose, misuse, abuse)
Country-specific reporting support
Select the country where the event occurred. Country-specific contact handling is enabled, and all countries currently route to our global
BLES pharmacovigilance contact while country-specific details are being finalized.
Selecting a country will display the applicable contact panel.
Pharmacovigilance Contact
Email:
Phone:
Mob:
Please include as much detail as possible, including product information, event description, patient initials/identifier,
reporter contact details and relevant dates.
You must be a medical professional to view these pages!
